RBFOX2 plays a dual role in that it is both an important co-regulator of ESRP1 in epithelial phenotype cells and a mesenchymal-specific splicing factor during EMT and in more aggressive breast cancer subtype cell lines [23, 40]. This evidence concerns the gene SLU7 and breast carcinoma.